We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$15.7B
AUM Growth
+$958M
Cap. Flow
-$459M
Cap. Flow %
-2.93%
Top 10 Hldgs %
22.96%
Holding
925
New
41
Increased
262
Reduced
364
Closed
130

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$97.5M
2
PYPL icon
PayPal
PYPL
+$66.8M
3
HOLX
Hologic
HOLX
+$44.4M
4
BNTX icon
BioNTech
BNTX
+$35M
5
TMO icon
Thermo Fisher Scientific
TMO
+$34.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$80.5M
2
XLRN
Acceleron Pharma
XLRN
+$79.5M
3
AAPL icon
Apple
AAPL
+$55.8M
4
ONC
BeOne Medicines Ltd
ONC
+$44.9M
5
VZ icon
Verizon
VZ
+$37.9M

Sector Composition

Rank Sector Weight
1 Healthcare 31.29%
2 Technology 26.69%
3 Financials 8.86%
4 Communication Services 7.82%
5 Consumer Discretionary 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CHNG
851
DELISTED
Change Healthcare Inc. Common Stock
CHNG
-553,958
Closed -$11.6M
RDUS
852
DELISTED
Radius Health, Inc.
RDUS
-403,068
Closed -$5M
EPZM
853
DELISTED
Epizyme, Inc
EPZM
-66,329
Closed -$340K
ZNGA
854
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
-25,700
Closed -$194K
PBCT
855
DELISTED
People's United Financial Inc
PBCT
-12,163
Closed -$212K
GTS
856
DELISTED
Triple-S Management Corporation
GTS
-176,192
Closed -$6.23M
SC
857
DELISTED
SANTANDER CONSUMER USA HOLDINGS INC
SC
-151,457
Closed -$6.32M
RDS.A
858
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
-100
Closed -$4K
DRNA
859
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
-393,390
Closed -$7.93M
LMRK
860
DELISTED
Landmark Infrastructure Partners LP Common Units
LMRK
-473,397
Closed -$7.74M
SOLY
861
DELISTED
Soliton, Inc.
SOLY
-239,086
Closed -$4.87M
KSU
862
DELISTED
Kansas City Southern
KSU
-37,848
Closed -$10.2M
HRC
863
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
-61,750
Closed -$9.26M
PPD
864
DELISTED
PPD, Inc. Common Stock
PPD
-669,870
Closed -$31.3M
DSPG
865
DELISTED
DSP Group Inc
DSPG
-286,076
Closed -$6.27M
CVA
866
DELISTED
Covanta Holding Corporation
CVA
-615,930
Closed -$12.4M
RAVN
867
DELISTED
Raven Industries Inc
RAVN
-105,343
Closed -$6.07M
INOV
868
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
-230,880
Closed -$9.3M
ECHO
869
DELISTED
Echo Global Logistics, Inc.
ECHO
-140,098
Closed -$8.31M
XLRN
870
DELISTED
Acceleron Pharma
XLRN
-462,239
Closed -$79.5M
CAI
871
DELISTED
CAI International, Inc.
CAI
-143,192
Closed -$8.01M
TRIL
872
DELISTED
Trillium Therapeutics Inc.
TRIL
-1,150,280
Closed -$20.2M
CNBKA
873
DELISTED
Century Bancorp Inc/Mass
CNBKA
-20,378
Closed -$2.35M
EBSB
874
DELISTED
Meridian Bancorp, Inc.
EBSB
-14,912
Closed -$310K
KDMN
875
DELISTED
Kadmon Holdings, Inc.
KDMN
-687,970
Closed -$5.99M

Similar funds

Candriam SCA's Q4 2021 Portfolio in Review

As of Q4 2021, Candriam SCA held 925 positions worth $15.7B, up 6.5% from $14.7B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Candriam SCA's Q4 2021 filing shows 41 new, 262 increased, 364 reduced and 130 closed positions. Its largest new stake was Couchbase: 858,038 shares worth $21.4M. The largest sale was Merck, an estimated $80.5M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2021 buy was Couchbase: 858,038 shares worth $21.4M.
  • Candriam SCA added most to Eli Lilly in Q4 2021, an estimated $97.5M increase.
  • Candriam SCA's biggest Q4 2021 reduction was Merck, cutting an estimated $80.5M.
  • Candriam SCA fully exited Acceleron Pharma in Q4 2021, selling an estimated $79.5M.
  • Candriam SCA's ten largest holdings make up 23% of its $15.7B portfolio in Q4 2021.
  • Candriam SCA opened 41 new positions and closed 130 in Q4 2021.
  • Candriam SCA's portfolio value rose 6.5% quarter-over-quarter to $15.7B.

Based on Candriam SCA's 13F filing for Q4 2021, filed 10 Feb 2022.